How much longer you might live without assistance on new Alzheimer’s drugs
New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.
Next-gen Alzheimer's drugs extend independent living by months
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...
Longwood Fund launches anxiety drug developer with $93.5M investment
A Boston VC firm is launching a new neuroscience company with a $93M investment that aims to treat disorders including ...
Methylene Blue: The ‘Magic’ Drug That’s Taking Over Social Media – But Is It Safe?
Methylene blue, a Victorian-era medicine, is making headlines after a video of RFK Jr. using it went viral. Touted as a cure ...
lupus.bmj2d
Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report
Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis.